This content is from: Banking

Brexit-driven governing law threats fail to materialise

Save for the odd outlier, English law continues to dominate loan markets. Here, Swiss pharma company Roche explains its rationale for switching

To access our in-house intelligence please request a trial here.

Read this article – and more – for a one-week period.

REQUEST ACCESS

Are you already an IFLR subscriber? Login here

Instant access to all of our content. Membership Options | One Week Trial